NUTR:NASDAQNusatrip Incorporated Analysis

NusaTrip (NUTR) trades at $9, exactly matching its 20‑day and 50‑day SMAs and sitting just above the 200‑day SMA of $8.39, indicating a neutral price trend. However, the RSI of 79.4 signals an overbought condition while the MACD histogram is negative and the signal line is labeled “bearish,” suggesting short‑term momentum weakness. The stock’s valuation metrics are extreme, with a price‑to‑book ratio of 13.9 and a price‑to‑sales multiple of 74.6, far above industry norms, and the company reports negative operating and net margins despite a nominal revenue growth of 3.4%. Adding to the concern, recent Nasdaq/SEC correspondence about a trading suspension raises a high regulatory risk, even though management asserts that operations remain unaffected.
Liquidity is another red flag: daily volume is reported as zero, the beta is essentially flat at -0.03, and 30‑day volatility is 0%, indicating a stagnant market with limited price discovery. While the balance sheet shows ample cash of $13.3 M versus modest debt, the negative free cash flow and deteriorating ROE/ROA underscore underlying profitability challenges. The Fear & Greed Index at 92.75 (Extreme Greed) reflects market euphoria that is not supported by fundamentals, making the stock vulnerable to a sharp correction.